GTBIF · Green Thumb Industries Inc.
$6.83
-0.28 (-3.94%)
At close · Jul 28
Market Cap
$1.33B
Shares
195.31M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.83
Open$7.06
Day$6.83–7.09
52W$5.29–10.43
Avg vol 30d352K
Short int49K · 0.0% float · 1.0d
Short vol43%
Last earningsAug 4, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 6
Up next
Next earnings call
Aug 4, 2026
Scheduled
· in 1 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 18.2 · elevated
Equity put/call 0.71
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−6%
below
Price vs 50-day avg
−9%
below
RSI (14)
38
neutral
MACD trend
Negative
52-week position
30%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−11%
trailing
6-month return
+2%
trailing
YTD return
−15%
this year
Relative strength
−6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow
Accumulating
3 of 5 funds reported for Jun 30 · net +9.3K sh shares · +1 new
Insider flow
Distributing
Net -$1.6K over 90 days · 100% sells
Short interest
Falling
0.03% of float · ▼ -68.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — mid 3-yr range
Squeeze score
37
low risk · 0–100
Fundamentals
Revenue growth
+3%
Y/Y
Gross margin
49%
contracting
EPS growth
+380%
Y/Y
Free cash flow
$213.9M
Valuation
P/E 18
below peers
Balance sheet
$27.0M
net cash
Quant / Vol
risk profile
Volatility
96%
annualized · 1-yr
Max drawdown
−42%
past year
ATR
4.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Mar 31, 2026
Full-year CapEx
· full-year
Initiated
$80M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−6%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
38
Neutral
MACD trend
Negative
Bearish
52-week position
30%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow
Accumulating
3 of 5 funds reported for Jun 30 · net +9.3K sh shares · +1 new
Insider flow
Distributing
Net -$1.6K over 90 days · 100% sells
Short interest
Falling
0.03% of float · ▼ -68.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
5 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $5
Now $7 · 30%
52-wk high $10
vs 200-day avg -6%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Normalized EBITDA non-GAAP | $93.5M | first quarter ended March 31, 2026 | — |
|
|
|||
| Normalized EBITDA margin non-GAAP | 31.2% | first quarter ended March 31, 2026 | — |
| Same store comparable sales | -0.5% | first quarter ended March 31, 2026 | — |
|
|
|||
| Cash flow from operations | $294.9M | FY2025 | — |
| Comparable stores base | 99 | Q4 FY2025 | — |
| Total stores nationwide | 113 | FY2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GTBIF
this stock
Green Thumb Industries Inc.
|
$1.33B | -15.0% | +3.7% | 18.0 | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$55.95B | +12.4% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$50.49B | +4.5% | — | — | 0.0% |
|
HLN
Haleon plc
|
$45.23B | +1.6% | — | — | 0.3% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GTBIF | -3.1% | -10.6% | +1.9% | -13.7% | -15.0% |
| SPY | -1.0% | 0.0% | +7.4% | -0.8% | +8.6% |
| vs SPY | -2.1% | -10.6% | -5.5% | -12.9% | -23.7% |